Quest Diagnostics Incorporated (DGX) Guidance & Earnings Results

On 2026-10-22 Quest Diagnostics Incorporated raised guidance: "FY26 revenue raised to $12.065-12.105B from $11.95-12.05B; FY26 adjusted EPS raised to $11.25-11.35 from $11.05-11.25; FY26 reported EPS $10.21-10.31 from $9.97-10.17; FY26 operating cash flow ~$1.90B from ~$1.80B;…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

DGXQuest Diagnostics IncorporatedFollow DGX — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 26.6B
P/E TTM: 24.1
Dividend yield: 1.4%
52-week: —
Next earnings: 8 Feb, in 106 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
22 Oct 26	Raised	FY26 revenue raised to $12.065-12.105B from $11.95-12.05B; FY26 adjusted EPS raised to $11.25-11.35 from $11.05-11.25; FY26 reported EPS $10.21-10.31 from $9.97-10.17; FY26 operating cash flow ~$1.90B from ~$1.80B; capex ~$550M unchanged · full year
23 Jul 26	Raised	FY26 revenue raised to $11.95-12.05B from $11.78-11.90B; FY26 reported EPS $9.97-10.17 from $9.58-9.78; FY26 adjusted EPS $11.05-11.25 from $10.63-10.83; FY26 operating cash flow ~$1.80B from ~$1.75B; FY26 capex ~$550M unchanged · full year
21 Apr 26	Raised	Revenue guidance raised by ~$80M at midpoint; adjusted EPS guidance raised by ~$0.13 at midpoint · full year
10 Feb 26	Raised	2026 revenue $11.70B-$11.82B; adjusted EPS $10.50-$10.70 · full year
12 Jan 26	Reaffirmed	4-5% revenue CAGR, 7-9% adjusted EPS CAGR beyond 2025 · full year
21 Oct 25	Raised	Net revenue guidance raised to $10.96B-$11.00B from $10.80B-$10.92B; adjusted EPS raised to $9.76-$9.84 from $9.63-$9.83 · full year

Quest Diagnostics Incorporated — questions

What guidance did Quest Diagnostics Incorporated give?: On 2026-10-22: "FY26 revenue raised to $12.065-12.105B from $11.95-12.05B; FY26 adjusted EPS raised to $11.25-11.35 from $11.05-11.25; FY26 reported EPS $10.21-10.31 from $9.97-10.17; FY26 operating cash flow ~$1.90B from ~$1.80B; capex ~$550M unchanged"
When does Quest Diagnostics Incorporated report earnings?: Quest Diagnostics Incorporated's next earnings report is expected on 2027-02-08.

Every figure on this page comes from Quest Diagnostics Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.